Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity

Biochimica et Biophysica Acta - General Subjects

Volumn 1862, Issue 6, 2018, Pages 1432-1442

  Leri, Manuela ^a   Oropesa Nuñez, Reiner ^b   Canale, Claudio ^b   Raimondi, Sara ^c   Giorgetti, Sofia ^c,d   Bruzzone, Elena ^a   Bellotti, Vittorio ^c,d,e   Stefani, Massimo ^a,e   Bucciantini, Monica ^a,e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Interuniversity Center for the Study of Neurodegenerative Diseases (CIMN)   (Italy)

Author keywords

Amyloid; D76N variant; Oleuropein aglycone; 2 microglobulin

Indexed keywords

AGLYCONE; AMYLOID; ASPARAGINE; ASPARTIC ACID; BETA 2 MICROGLOBULIN; MEMBRANE PROTEIN; OLEUROPEIN; POLYPHENOL; PROTEIN VARIANT; ACETIC ACID; OLEUROPEIN AGLYCONE; PYRAN DERIVATIVE;

ABDOMINAL DISEASE; AMYLOIDOSIS; ARTICLE; BIOPHYSICS; CELL INTERACTION; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DRUG MECHANISM; DRUG TARGETING; FAMILIAL AMYLOIDOSIS; HUMAN; HUMAN CELL; INTESTINE FUNCTION DISORDER; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN MISFOLDING; PROTEIN MODIFICATION; APOPTOSIS; ARTIFICIAL MEMBRANE; DRUG EFFECT; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL CULTURE;

ACETATES; AMYLOID; AMYLOIDOSIS; APOPTOSIS; BETA 2-MICROGLOBULIN; HUMANS; MEMBRANES, ARTIFICIAL; NEUROBLASTOMA; PYRANS; TUMOR CELLS, CULTURED;

EID: 85044537204     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2018.03.023     Document Type: Article

References (47)

1. Stefani, M., Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits. Prog. Neurobiol. 99 (2012), 226–245.
2. Stefani, M., Rigacci, S., Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors 40 (2014), 482–493.
3. Bhullar, K.S., Vasantha Rupasinghe, H.P., Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxidative Med. Cell. Longev., 2013, 2013, 891748.
4. Queen, B.L., Tollefsbol, T.O., Polyphenols and aging. Curr. Aging Sci. 3 (2010), 34–42.
5. Scarmeas, N.Y., Stern, M.X., Tang, R., Mayeux, J.A., Luchsinger, J.A., Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 59 (2006), 912–921.
6. Ladiwala, A.R., Mora-Pale, M., Lin, J.C., Bale, S.S., Fishman, Z.S., Dordick, J.S., Tessier, P.M., Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β. Chembiochem 12:11 (2011), 1749–1758.
7. Rigacci, S., Guidotti, V., Bucciantini, M., Parri, M., Nediani, C., Cerbai, E., Stefani, M., Berti, A., Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J. Nutr. Biochem. 21:8 (2010), 726–735.
8. Rigacci, S., Guidotti, V., Bucciantini, M., Nichino, D., Relini, A., Berti, A., Stefani, M., Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr. Alzheimer Res. 8:8 (2011), 841–852.
9. Leri, M., Nosi, D., Natalello, A., Porcari, R., Ramazzotti, M., Chiti, F., Bellotti, V., Doglia, S.M., Stefani, M., Bucciantini, M., The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. J. Nutr. Biochem. 30 (2016), 153–166.
10. Ladiwala, A.R., Dordick, J.S., Tessier, P.M., Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J. Biol. Chem. 286:5 (2011), 3209–3218.
11. Diomede, L., Rigacci, S., Romeo, M., Stefani, M., Salmona, M., Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit. PLoS One, 8(3), 2013, e58893.
12. Grossi, C., Rigacci, S., Ambrosini, S., Ed Dami, T., Luccarini, I., Traini, C., Failli, P., Berti, A., Casamenti, F., Stefani, M., The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology. PLoS One, 8(8), 2013, e71702.
13. Luccarini, I., Ed Dami, T., Grossi, C., Rigacci, S., Stefani, M., Casamenti, F., Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain. Neurosci. Lett. 558 (2014), 67–72.
14. Galiano, V., Villalaín, J., Oleuropein aglycone in lipid bilayer membranes. A molecular dynamics study. J. Biochim. Biophys. Acta. 1848 (2015), 2849–2858.
15. Williams, L.T., Serpell, L.C., Membrane and surface interactions of Alzheimer's Aβ peptide – insights into the mechanism of cytotoxicity. FEBS J. 278:20 (2011), 3905–3917.
16. Cecchi, C., Stefani, M., The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophys. Chem. 182 (2013), 30–43.
17. Bucciantini, M., Nosi, D., Forzan, M., Russo, E., Calamai, M., Pieri, L., Formigli, L., Quercioli, F., Soria, S., Pavone, F., Savistchenko, J., Melki, R., Stefani, M., Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1. FASEB J. 26:2 (2012), 818–831.
18. C. Canale, R. Oropesa-Nuñez, A. Diaspro, S. Dante. Amyloid and membrane complexity: the toxic interplay revealed by AFM. Semin. Cell Dev. Biol. https://doi.org/10.1016/j.semcdb.2017.08.046.
19. Walsh, P., Vanderlee, G., Yau, J., Campeau, J., Sim, V.L., Yip, C.M., Sharpe, S., The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by PrP(106–126) is dependent on bilayer composition. JBC. 289 (2014), 10419–10430.
20. Valleix, S., Gillmore, J.D., Bridoux, F., Mangione, P.P., Dogan, A., Nedelec, B., Boimard, M., Touchard, G., Goujon, J.M., Lacombe, C., Lozeron, P., Adams, D., Lacroix, C., Maisonobe, T., Planté-Bordeneuve, V., Vrana, J.A., Theis, J.D., Giorgetti, S., Porcari, R., Ricagno, S., Bolognesi, M., Stoppini, M., Delpech, M., Pepys, M.B., Hawkins, P.N., Bellotti, V., Hereditary systemic amyloidosis due to Asp76Asn variant beta2-microglobulin. N. Engl. J. Med. 366 (2012), 2276–2283.
21. Leri, M., Bemporad, F., Oropesa-Nuñez, R., Canale, C., Calamai, M., Nosi, D., Ramazzotti, M., Giorgetti, S., Pavone, F.S., Bellotti, V., Stefani, M., Bucciantini, M., Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2-microglobulin. J. Cell. Mol. Med. 20:8 (2016), 1443–1456.
22. P.P. Mangione, G. Esposito, A. Relini, S. Raimondi, R. Porcari, S. Giorgetti, A. Corazza, F. Fogolari, A. Penco, Y. Goto, Y.H. Lee, H. Yagi, C. Cecconi, M.M. Naqvi, J.D. Gillmore, P.N. Hawkins, F. Chiti, R. Rolandi, G.W, Taylor, M.B. Pepys, M. Stoppini, V. Bellotti, Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallin. J. Biol. Chem. 288(43) (2013) 30917–30.
23. Eichner, T., Radford, S.E., Understanding the complex mechanisms of beta2-microglobulin amyloid assembly. FEBS J. 278 (2011), 3868–3883.
24. Yang, J.E., Rhoo, K.Y., Lee, S., Lee, J.T., Park, J.H., Bhak, G., Paik, S.R., EGCG-mediated protection of the membrane disruption and cytotoxicity caused by the ‘active oligomer’ of α-synuclein. Sci. Rep., 7(1), 2017, 17945.
25. Nilsson, M.R., Techniques to study amyloid fibril formation in vitro. Methods 34:1 (2004), 151–160.
26. Frid, P., Anisimov, S.V., Popovic, N., Congo red and protein aggregation in neurodegenerative diseases. Brain Res. Rev. 53:1 (2007), 135–160.
27. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:1–2 (1983), 55–63.
28. Nosi, D., Mercatelli, R., Chellini, F., Soria, S., Pini, A., Formigli, L., Quercioli, F., A molecular imaging analysis of Cx43 association with Cdo during skeletal myoblast differentiation. J. Biophotonics 6:8 (2013), 612–621.
29. Seghezza, S., Dante, S., Diaspro, A., Canale, C., High resolution nanomechanical characterization of multi-domain model membranes by fast force volume. J. Mol. Recognit. 28:12 (2015), 742–750.
30. Habchi, J., Chia, S., Limbocker, R., Mannini, B., Ahn, M., Perni, M., Hansson, O., Arosio, P., Kumita, J.R., Challa, P.K., Cohen, S.I.A., Linse, S., Dobson, C.M., Knowles, T.P.J., Vendruscolo, M., Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease. PNAS 114:2 (2017), E200–E208.
31. Raimondi, S., Barbarini, N., Mangione, P., Esposito, G., Ricagno, S., Bolognesi, M., Zorzoli, I., Marchese, L., Soria, C., Bellazzi, R., Monti, M., Stoppini, M., Stefanelli, M., Magni, P., Bellotti, V., The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. BMC Evol. Biol., 11, 2011, 159.
32. Santambrogio, C., Ricagno, S., Colombo, M., Barbiroli, A., Bonomi, F., Bellotti, V., Bolognesi, M., Grandori, R., DE-loop mutations affect beta2 microglobulin stability, oligomerization, and the low-pH unfolded form. Protein Sci. 19:7 (2010), 1386–1394.
33. Camilleri, A., Zarb, C., Caruana, M., Ostermeier, U., Ghio, S., Högen, T., Schmidt, F., Giese, A., Vassallo, N., Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols. Biochim. Biophys. Acta 1828:11 (2013), 2532–2543.
34. Ohta, Y., Yokoyama, S., Sakai, H., Abe, M., Membrane properties of binary and ternary systems of ganglioside GM1/dipalmitoylphosphatidylcholine/dioleoylphosphatidylcholine. Colloids Surf. B: Biointerfaces 34:3 (2004), 147–153.
35. Bucciantini, M., Rigacci, S., Stefani, M., Amyloid aggregation: role of biological membranes and the aggregate-membrane system. J. Phys. Chem. Lett. 5:3 (2014), 517–527.
36. Giorgetti, S., Raimondi, S., Cassinelli, S., Bucciantini, M., Stefani, M., Gregorini, G., Albonico, G., Moratti, R., Montagna, G., Stoppini, M., Bellotti, V., beta2-Microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. Nephrol. Dial. Transplant. (24), 2009, 1176–1181.
37. Evangelisti, E., Cascella, R., Becatti, M., Marrazza, G., Dobson, C.M., Chiti, F., Stefani, M., Cecchi, C., Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases. Sci. Rep., 6, 2016, 32721.
38. Oropesa-Nuñez, R., Seghezza, S., Dante, S., Diaspro, A., Cascella, R., Cecchi, C., Stefani, M., Chiti, F., Canale, C., Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy. Oncotarget 7:29 (2016), 44991–45004.
39. Merlini, G., Seldin, D.C., Gertz, M.A., Amyloidosis: pathogenesis and new therapeutic options. J. Clin. Oncol. 29:14 (2011), 1924–1933.
40. Bucciantini, M., Cecchi, C., Biological membranes as protein aggregation matrices and targets of amyloid toxicity. Methods Mol. Biol. 648 (2010), 231–243.
41. Hirakura, Y., Kagan, B.L., Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis. Amyloid 8:2 (2001), 94–100.
42. Pellistri, F., Bucciantini, M., Invernizzi, G., Gatta, E., Penco, A., Frana, A.M., Nosi, D., Relini, A., Regonesi, M.E., Gliozzi, A., Tortora, P., Robello, M., Stefani, M., Different ataxin-3 amyloid aggregates induce intracellular Ca(2+) deregulation by different mechanisms in cerebellar granule cells. Biochim. Biophys. Acta 1833:12 (2013), 3155–3165.
43. Mannini, B., Mulvihill, E., Sgromo, C., Cascella, R., Khodarahmi, R., Ramazzotti, M., Dobson, C.M., Cecchi, C., Chiti, F., Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem. Biol. 9:10 (2014), 2309–2317.
44. Wakabayashi, M., Matsuzaki, K., Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts. FEBS Lett. 583:17 (2009), 2854–2858.
45. Del Rio, D., Rodriguez-Mateos, A., Spencer, J.P.E., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 18:14 (2013), 1818–1892.
46. Virmani, A., Pinto, L., Binienda, Z., Ali, S., Food, nutrigenomics, and neurodegeneration — neuroprotection by what you eat!. Mol. Neurobiol. 48 (2013), 353–362.
47. Hoernke, M., Tassler, S., Koksch, B., Brezesinski, G., Membrane binding of peptide models for early stages of amyloid formation: lipid packing counts more than charge. Chem. Phys. Lipids 198 (2016), 28–38.